Keiji Shimizu1,2, Seiichi Yamamoto3, Keiichi Matsumoto4, Megumu Hino5, Michio Senda6. 1. Nagoya University Graduate School of Medicine, 1-1-20 Daiko-Minami, Higashi-ku, Nagoya City, Aichi, 461-8673, Japan. k-shimizu@kcho.jp. 2. Department of Radiological Technology, Kobe City Medical Center General Hospital, 2-1-1, Minatojima-Minamimachi, Chuo-Ku, Kobe-City, Hyogo, 650-0047, Japan. k-shimizu@kcho.jp. 3. Nagoya University Graduate School of Medicine, 1-1-20 Daiko-Minami, Higashi-ku, Nagoya City, Aichi, 461-8673, Japan. 4. Kyoto College of Medical Science, 1-3, Oyama-Higashimachi-Imakita, Sonobe-Cho, Nantan-City, Kyoto, 622-0041, Japan. 5. Department of Radiological Technology, Kobe City Medical Center General Hospital, 2-1-1, Minatojima-Minamimachi, Chuo-Ku, Kobe-City, Hyogo, 650-0047, Japan. 6. Institute of Biomedical Research and Innovation, 2-2, Minatojima Minamimachi, Chuo-ku, Hyogo, 650-0047, Japan.
Abstract
PURPOSE: In Japan, commercially delivered FDG is manufactured in three batches per day at fixed constant activity and distributed in vials. Consequently, the amount of activity administered to the patient varies depending on the timing of injection. We evaluated a method for adjusting the scan time according to the body mass index (BMI) to obtain equivalent image quality for every patient. METHODS: We examined a total of 301 routine clinical oncology PET scans using commercially delivered FDG. The relation between the injected activity and the noise equivalent count per scan length (NECpatient) was evaluated as a marker of image quality; its association with BMI was also examined. RESULTS: The injected activity and NECpatient exhibited large variations (230.4 ± 55.8 MBq and 19.9 ± 2.9 Mcounts/m). There was a weak correlation between the injected activity and NECpatient (r ~ 0.3) for thin patients (BMI < 21 kg/m(2)), but no correlation for patients with higher BMIs. However, a significant correlation was found between BMI and NECpatient (p < 0.0001). CONCLUSION: In a community hospital using commercially delivered FDG, it is possible to reduce the variability of the NECpatient and obtain uniform image quality by changing the scan time as a function of patient BMI, even with uncontrollable injected activity.
PURPOSE: In Japan, commercially delivered FDG is manufactured in three batches per day at fixed constant activity and distributed in vials. Consequently, the amount of activity administered to the patient varies depending on the timing of injection. We evaluated a method for adjusting the scan time according to the body mass index (BMI) to obtain equivalent image quality for every patient. METHODS: We examined a total of 301 routine clinical oncology PET scans using commercially delivered FDG. The relation between the injected activity and the noise equivalent count per scan length (NECpatient) was evaluated as a marker of image quality; its association with BMI was also examined. RESULTS: The injected activity and NECpatient exhibited large variations (230.4 ± 55.8 MBq and 19.9 ± 2.9 Mcounts/m). There was a weak correlation between the injected activity and NECpatient (r ~ 0.3) for thin patients (BMI < 21 kg/m(2)), but no correlation for patients with higher BMIs. However, a significant correlation was found between BMI and NECpatient (p < 0.0001). CONCLUSION: In a community hospital using commercially delivered FDG, it is possible to reduce the variability of the NECpatient and obtain uniform image quality by changing the scan time as a function of patient BMI, even with uncontrollable injected activity.
Authors: Gerhard W Goerres; Cyrill Burger; Ehab Kamel; Burkhardt Seifert; Achim H Kaim; Alfred Buck; Tobias C Buehler; Gustav K Von Schulthess Journal: Radiology Date: 2003-03 Impact factor: 11.105
Authors: E De Ponti; S Morzenti; L Guerra; C Pasquali; M Arosio; V Bettinardi; A Crespi; M C Gilardi; C Messa Journal: Med Phys Date: 2011-02 Impact factor: 4.071
Authors: Charles C Watson; Michael E Casey; Bernard Bendriem; Jonathan P Carney; David W Townsend; Stefan Eberl; Steve Meikle; Frank P Difilippo Journal: J Nucl Med Date: 2005-11 Impact factor: 10.057
Authors: Ronald Boellaard; Roberto Delgado-Bolton; Wim J G Oyen; Francesco Giammarile; Klaus Tatsch; Wolfgang Eschner; Fred J Verzijlbergen; Sally F Barrington; Lucy C Pike; Wolfgang A Weber; Sigrid Stroobants; Dominique Delbeke; Kevin J Donohoe; Scott Holbrook; Michael M Graham; Giorgio Testanera; Otto S Hoekstra; Josee Zijlstra; Eric Visser; Corneline J Hoekstra; Jan Pruim; Antoon Willemsen; Bertjan Arends; Jörg Kotzerke; Andreas Bockisch; Thomas Beyer; Arturo Chiti; Bernd J Krause Journal: Eur J Nucl Med Mol Imaging Date: 2014-12-02 Impact factor: 9.236
Authors: Eleonore H de Groot; Nieky Post; Ronald Boellaard; Nils Rl Wagenaar; Antoon Tm Willemsen; Jorn A van Dalen Journal: EJNMMI Res Date: 2013-08-12 Impact factor: 3.138